State Street Corp Lipocine Inc. Transaction History

State Street Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.73 - $1.34 $7,863 - $14,434	-10,772 Reduced 3.29%	316,633 $254,000
Q1 2022 May 16, 2022	BUY	$0.89 - $1.85 $20,281 - $42,157	22,788 Added 7.48%	327,405 $449,000
Q2 2021 Aug 16, 2021	BUY	$1.17 - $1.59 $341,893 - $464,625	292,217 Added 2356.59%	304,617 $426,000
Q1 2020 May 11, 2020	BUY	$0.32 - $0.77 $3,968 - $9,548	12,400 New	12,400 $6,000

Ticker LPCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 88,510,800
Market Cap $433M
Description
Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Its lead product candidate is TLANDO, an oral testosterone rep...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.